COR-L47Homo sapiens (Human)Cancer cell line

Also known as: CORL47, Cor L47

🤖 AI SummaryBased on 8 publications

Quick Overview

Human small cell lung cancer cell line with known genetic and molecular characteristics.

Detailed Summary

COR-L47 is a human small cell lung cancer (SCLC) cell line established from a bone marrow aspirate. It is characterized by specific genetic alterations, including amplification of the c-myc gene and deletions in chromosome 3. The cell line exhibits distinct morphological and biochemical features, such as low expression of neuroendocrine markers and variable levels of L-dopa decarboxylase. COR-L47 has been used in studies investigating the molecular mechanisms of SCLC, including the role of oncogenes and chromosomal abnormalities in tumor progression. It is also utilized in research on drug sensitivity and resistance, contributing to the understanding of therapeutic strategies for SCLC. The cell line's genetic profile and behavior make it a valuable model for studying the biology of small cell lung cancer.

Research Applications

Molecular mechanisms of SCLCOncogene amplification studiesChromosomal abnormalities in cancerDrug sensitivity and resistanceTumor biology and progression

Key Characteristics

Amplification of c-mycDeletion in chromosome 3Variable L-dopa decarboxylase expressionLow neuroendocrine marker expression
Generated on 6/18/2025

Basic Information

Database IDCVCL_2415
SpeciesHomo sapiens (Human)
Tissue SourceBone marrow[UBERON:UBERON_0002371]

Donor Information

Age67
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseSmall cell lung cancer
LineageLung
SubtypeSmall Cell Lung Cancer
OncoTree CodeSCLC

DepMap Information

Source TypeECACC
Source IDACH-000695_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg306Ter (c.916C>T)HeterozygousGermlinePubMed=16418264
MutationSimplePTENp.Glu18Ter (c.52G>T)Homozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,12
D13S317
11
D16S539
11,12
D18S51
13,15
D21S11
30,31.2
D3S1358
14
D5S818
10,13
D7S820
8,10
D8S1179
12,14
FGA
24
Penta D
9,12
Penta E
11,12
TH01
6,8
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization.

Cawkwell L.

Int. J. Cancer 102:230-236(2002).

Oncogene amplification and chromosomal abnormalities in small cell lung cancer.

Ibson J.M., Waters J.J., Twentyman P.R., Bleehen N.M., Rabbitts P.H.

J. Cell. Biochem. 33:267-288(1987).

Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

Watson J.V., Johnson N., Reeve J.G., Bleehen N.M.

Br. J. Cancer 52:495-504(1985).